Mandelic AcidvsSalicylic Acid

Mandelic acid (152 Da, the largest common AHA) exfoliates through calcium chelation and corneodesmosome disruption like other AHAs, but its large molecular size results in slower, more even epidermal penetration with reduced risk of hot-spot irritation and stratum corneum over-exfoliation. Its phenyl ring confers partial lipophilicity, enabling penetration into the pilosebaceous unit and follicular infundibulum—unlike purely hydrophilic glycolic and lactic acids. Within pores, mandelic acid exerts mild comedolytic effects by disrupting keratinocyte cohesion in the follicular epithelium, similar to salicylic acid. It demonstrates antibacterial activity against Cutibacterium acnes (Propionibacterium acnes) through membrane disruption. Mandelic acid also inhibits tyrosinase and reduces melanosome transfer to keratinocytes, providing brightening benefits. This profile makes it particularly suitable for acne-prone skin, hyperpigmentation, and darker skin tones (Fitzpatrick IV–VI) where gentler exfoliation minimizes post-inflammatory hyperpigmentation risk.

Salicylic acid (ortho-hydroxybenzoic acid) is a lipophilic beta-hydroxy acid—the ortho hydroxyl enables sebum and follicular lipid solubility, unlike water-soluble AHAs. It penetrates the pilosebaceous unit and induces desmolysis: disruption of desmosomal attachments and corneodesmosomes, accelerating desquamation of pore-clogging debris. Inside the follicle, it dissolves sebum and keratin plugs (comedolysis). Salicylic acid inhibits COX-1 and COX-2, reducing prostaglandin synthesis—the same anti-inflammatory mechanism as aspirin—decreasing erythema and swelling. Bacteriostatic against Cutibacterium acnes through membrane disruption and pH reduction. May reduce sebum production. Small size (138 Da) and lipophilicity enable follicular penetration to depths AHAs cannot reach.